MX9306528A - Derivados de sulfonamida de compuestos anulares de cicloalquilo-heterociclico substituidos con hidroxi, de benceno fundido. - Google Patents
Derivados de sulfonamida de compuestos anulares de cicloalquilo-heterociclico substituidos con hidroxi, de benceno fundido.Info
- Publication number
- MX9306528A MX9306528A MX9306528A MX9306528A MX9306528A MX 9306528 A MX9306528 A MX 9306528A MX 9306528 A MX9306528 A MX 9306528A MX 9306528 A MX9306528 A MX 9306528A MX 9306528 A MX9306528 A MX 9306528A
- Authority
- MX
- Mexico
- Prior art keywords
- hetero
- cycloalkyl
- hydroxy
- annular
- cyclic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96433792A | 1992-10-21 | 1992-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9306528A true MX9306528A (es) | 1994-06-30 |
Family
ID=25508435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9306528A MX9306528A (es) | 1992-10-21 | 1993-10-20 | Derivados de sulfonamida de compuestos anulares de cicloalquilo-heterociclico substituidos con hidroxi, de benceno fundido. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5641789A (OSRAM) |
| EP (1) | EP0665842A1 (OSRAM) |
| JP (1) | JPH07508534A (OSRAM) |
| KR (1) | KR950704309A (OSRAM) |
| CN (1) | CN1090282A (OSRAM) |
| AP (1) | AP9300578A0 (OSRAM) |
| AU (1) | AU5536794A (OSRAM) |
| BR (1) | BR9307277A (OSRAM) |
| CA (1) | CA2146261A1 (OSRAM) |
| CZ (1) | CZ100095A3 (OSRAM) |
| FI (1) | FI934625L (OSRAM) |
| HR (1) | HRP931297A2 (OSRAM) |
| HU (1) | HUT68323A (OSRAM) |
| IL (1) | IL107294A0 (OSRAM) |
| MA (1) | MA23009A1 (OSRAM) |
| MX (1) | MX9306528A (OSRAM) |
| NO (1) | NO303224B1 (OSRAM) |
| PL (1) | PL308474A1 (OSRAM) |
| RU (1) | RU95109929A (OSRAM) |
| SI (1) | SI9300554A (OSRAM) |
| TW (1) | TW265335B (OSRAM) |
| WO (1) | WO1994008996A1 (OSRAM) |
| ZA (1) | ZA937782B (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5539128A (en) * | 1994-11-30 | 1996-07-23 | Pfizer Inc. | Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy chroman-3-ylmethyl]-4-methoxyaniline |
| US6075016A (en) | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
| JP3117730B2 (ja) * | 1996-09-16 | 2000-12-18 | ファイザー・インク | 置換クロマール誘導体を製造するための方法及び中間体 |
| ZA981080B (en) * | 1997-02-11 | 1998-08-12 | Warner Lambert Co | Bicyclic inhibitors of protein farnesyl transferase |
| GB9800039D0 (en) * | 1998-01-02 | 1998-03-04 | Univ Cardiff | Benzyl and benzylidene tetralins and derivatives |
| RU2182004C1 (ru) * | 2001-02-22 | 2002-05-10 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Лекарственный препарат для парентерального применения |
| EP1386919A4 (en) * | 2001-04-10 | 2010-03-10 | Takara Bio Inc | REMEDIES |
| WO2004035741A2 (en) * | 2002-10-17 | 2004-04-29 | Decode Genetics Ehf. | Susceptibility gene for myocardial infarction; methods of treatment |
| US20080293750A1 (en) * | 2002-10-17 | 2008-11-27 | Anna Helgadottir | Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment |
| US20060019269A1 (en) * | 2002-10-17 | 2006-01-26 | Decode Genetics, Inc. | Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment |
| US7507531B2 (en) * | 2002-10-17 | 2009-03-24 | Decode Genetics Chf. | Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction |
| US7851486B2 (en) * | 2002-10-17 | 2010-12-14 | Decode Genetics Ehf. | Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment |
| EP1670445A2 (en) * | 2003-09-17 | 2006-06-21 | Decode Genetics EHF. | Methods of preventing or treating recurrence of myocardial infarction |
| US20100216863A1 (en) * | 2004-01-30 | 2010-08-26 | Decode Genetics Ehf. | Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment |
| US8158362B2 (en) * | 2005-03-30 | 2012-04-17 | Decode Genetics Ehf. | Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype |
| US20060210514A1 (en) * | 2005-03-18 | 2006-09-21 | Mower Thomas E | Skin protection and moisturizing compositions and method of making the same |
| CN119912349B (zh) * | 2023-10-31 | 2025-11-21 | 中国石油天然气股份有限公司 | 一种可降解凝胶用交联剂、制备方法及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059609A (en) * | 1987-10-19 | 1991-10-22 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
| US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| WO1990015801A1 (en) * | 1989-06-22 | 1990-12-27 | Pfizer Inc. | Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases |
-
1993
- 1993-09-30 JP JP6510027A patent/JPH07508534A/ja active Pending
- 1993-09-30 CA CA002146261A patent/CA2146261A1/en not_active Abandoned
- 1993-09-30 WO PCT/US1993/009171 patent/WO1994008996A1/en not_active Ceased
- 1993-09-30 AU AU55367/94A patent/AU5536794A/en not_active Abandoned
- 1993-09-30 BR BR9307277A patent/BR9307277A/pt not_active Application Discontinuation
- 1993-09-30 CZ CZ951000A patent/CZ100095A3/cs unknown
- 1993-09-30 US US08/416,681 patent/US5641789A/en not_active Expired - Fee Related
- 1993-09-30 PL PL93308474A patent/PL308474A1/xx unknown
- 1993-09-30 RU RU95109929/04A patent/RU95109929A/ru unknown
- 1993-09-30 EP EP94900348A patent/EP0665842A1/en not_active Ceased
- 1993-09-30 KR KR1019950701525A patent/KR950704309A/ko not_active Ceased
- 1993-10-06 TW TW082108282A patent/TW265335B/zh active
- 1993-10-07 AP APAP/P/1993/000578A patent/AP9300578A0/en unknown
- 1993-10-14 IL IL107294A patent/IL107294A0/xx unknown
- 1993-10-18 HR HR07/964,337A patent/HRP931297A2/xx not_active Application Discontinuation
- 1993-10-20 MA MA23314A patent/MA23009A1/fr unknown
- 1993-10-20 HU HU9302969A patent/HUT68323A/hu unknown
- 1993-10-20 FI FI934625A patent/FI934625L/fi not_active Application Discontinuation
- 1993-10-20 SI SI9300554A patent/SI9300554A/sl unknown
- 1993-10-20 MX MX9306528A patent/MX9306528A/es unknown
- 1993-10-20 CN CN93119221A patent/CN1090282A/zh active Pending
- 1993-10-20 ZA ZA937782A patent/ZA937782B/xx unknown
-
1995
- 1995-04-20 NO NO951506A patent/NO303224B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2146261A1 (en) | 1994-04-28 |
| RU95109929A (ru) | 1997-03-20 |
| KR950704309A (ko) | 1995-11-17 |
| FI934625A7 (fi) | 1994-04-22 |
| HUT68323A (en) | 1995-06-28 |
| TW265335B (OSRAM) | 1995-12-11 |
| AU5536794A (en) | 1994-05-09 |
| BR9307277A (pt) | 1999-05-11 |
| AP9300578A0 (en) | 1995-04-07 |
| HU9302969D0 (en) | 1993-12-28 |
| ZA937782B (en) | 1995-04-20 |
| EP0665842A1 (en) | 1995-08-09 |
| PL308474A1 (en) | 1995-08-07 |
| NO951506L (no) | 1995-04-20 |
| WO1994008996A1 (en) | 1994-04-28 |
| JPH07508534A (ja) | 1995-09-21 |
| US5641789A (en) | 1997-06-24 |
| HRP931297A2 (en) | 1996-08-31 |
| IL107294A0 (en) | 1994-01-25 |
| MA23009A1 (fr) | 1994-07-01 |
| CN1090282A (zh) | 1994-08-03 |
| FI934625A0 (fi) | 1993-10-20 |
| SI9300554A (en) | 1995-04-30 |
| NO951506D0 (no) | 1995-04-20 |
| NO303224B1 (no) | 1998-06-15 |
| FI934625L (fi) | 1994-04-22 |
| CZ100095A3 (en) | 1995-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2117133T3 (es) | Derivados peptidilicos del acido 4-amino-2,2-difluoro-3-oxo-1,6-hexanodioico como agentes antiinflamatorios. | |
| BR0206435A (pt) | Composto, composição farmacêutica, métodos de tratar a angiogênese em um paciente, de tratar distúrbios relacionados com kdr e proliferativos em um mamìfero, uso de um composto, e, processo para preparar compostos | |
| AR029634A1 (es) | Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento | |
| AR007118A1 (es) | 4(3h)-quinazolinonas 2,3 disustituidas y composiciones farmaceuticas que las contienen | |
| ES2104946T3 (es) | Ureas ciclicas y similares utiles como inhibidores de la proteasa retrovirica. | |
| AP9300578A0 (en) | Sulfonamide derivatives of benzenefused, hydroxy substituted cycloalkyl and heterocyclic ring compounds. | |
| ES542320A0 (es) | Un procedimiento para la preparacion de derivados de la 2 pirimidinil 1 piperazina | |
| ES2055056T3 (es) | Derivados de pirimidopirimidina. | |
| ES2164920T3 (es) | Nuevos derivados heterociclicos y uso medicinal de los mismos. | |
| ECSP034917A (es) | Nuevos derivados de acido sulfonico | |
| MX9301240A (es) | Derivados heterociclicos de cetona, condensados, metodo para su produccion y composicion farmaceutica que los contiene. | |
| MX9305256A (es) | Derivados de 7-isoindolinil-quinolona y derivados de7-isoindolinil-naftiridona, proceso para su preparacion y medicamentos quelos contienen. | |
| ES8305714A1 (es) | Procedimiento para la produccion de derivados de piperidile-no | |
| NO168582C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskvirksomme dihydrobenzofuran- og chroman-carboxamidderivater | |
| ES2089255T3 (es) | N-(ariloxialquil)heteroaril-8-azabiciclo(3.2.1)octanos, compuestos intermedios y un procedimiento para su preparacion y su uso como medicamentos. | |
| ES2152237T3 (es) | Pirazolo(4,3-c)piridinas, un procedimiento para su preparacion y su uso como inhibidores de la recaptacion de serotonina. | |
| NO950683D0 (no) | Nye 2-substituterte indan-2-merkaptoacetylamidtrisykliske derivater som er anvendbare som inhibitorer av enkefalinase | |
| ES2152682T3 (es) | Derivados de indolina utiles como antagonistas del receptor 5ht-2c. | |
| ES2061681T3 (es) | Cromados sustituidos y compuestos relacionados en el tratamiento del asma. | |
| ES2153457T3 (es) | Amino-alquil-benzoxazolinonas y benzotiazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| NO176097C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksener | |
| ES2172023T3 (es) | Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2068497T3 (es) | Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen. | |
| ES2130548T3 (es) | Nuevos derivados alquil-amino-indanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2160955T3 (es) | Derivados del acido 4-arilbutirico sustituido como inhibidores de la metaloproteasa de matriz. |